Healthcare provider profile · identity verified

William Joseph Lago, M.D.

Family Practice · LOUISVILLE, OH · NPI 1467439232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	755	215
Levothyroxine Sodium	Levothyroxine Sodium	598	130
Omeprazole	Omeprazole	588	153
Lisinopril	Lisinopril	573	160
Amlodipine Besylate	Amlodipine Besylate	475	126
Losartan Potassium	Losartan Potassium	361	99
Pantoprazole Sodium	Pantoprazole Sodium	354	84
Metoprolol Succinate	Metoprolol Succinate	339	98
Gabapentin	Gabapentin	293	78
Metformin Hcl	Metformin Hcl	271	84
Metoprolol Tartrate	Metoprolol Tartrate	243	56
Sertraline Hcl	Sertraline Hcl	224	61
Furosemide	Furosemide	220	56
Potassium Chloride	Potassium Chloride	214	52
Simvastatin	Simvastatin	212	54
Hydrochlorothiazide	Hydrochlorothiazide	207	64
Metformin Hcl Er	Metformin Hcl	197	57
Trulicity	Dulaglutide	186	32
Eliquis	Apixaban	176	39
Rosuvastatin Calcium	Rosuvastatin Calcium	172	47
Trazodone Hcl	Trazodone Hcl	170	39
Pravastatin Sodium	Pravastatin Sodium	153	47
Tamsulosin Hcl	Tamsulosin Hcl	144	40
Albuterol Sulfate Hfa	Albuterol Sulfate	142	60
Famotidine	Famotidine	136	41
Duloxetine Hcl	Duloxetine Hcl	134	30
Glimepiride	Glimepiride	119	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	118	29
Clopidogrel	Clopidogrel Bisulfate	116	37
Carvedilol	Carvedilol	115	36
Atenolol	Atenolol	107	35
Warfarin Sodium	Warfarin Sodium	106	24
Montelukast Sodium	Montelukast Sodium	100	23
Buspirone Hcl	Buspirone Hcl	90	16
Fluoxetine Hcl	Fluoxetine Hcl	90	26
Xarelto	Rivaroxaban	84	12
Bupropion Xl	Bupropion Hcl	76	22
Citalopram Hbr	Citalopram Hydrobromide	76	21
Fluticasone Propionate	Fluticasone Propionate	76	25
Spironolactone	Spironolactone	76	19
Allopurinol	Allopurinol	75	22
Synthroid	Levothyroxine Sodium	74	19
Januvia	Sitagliptin Phosphate	73	13
Ezetimibe	Ezetimibe	67	17
Meloxicam	Meloxicam	67	27
Valsartan	Valsartan	66	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	21
Jardiance	Empagliflozin	64	17
Escitalopram Oxalate	Escitalopram Oxalate	63	19
Prednisone	Prednisone	63	42
Venlafaxine Hcl Er	Venlafaxine Hcl	62	15
Doxazosin Mesylate	Doxazosin Mesylate	60	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	58	suppressed
Finasteride	Finasteride	57	19
Tizanidine Hcl	Tizanidine Hcl	57	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	16
Donepezil Hcl	Donepezil Hcl	54	suppressed
Ropinirole Hcl	Ropinirole Hcl	54	12
Alendronate Sodium	Alendronate Sodium	53	15
Topiramate	Topiramate	52	11
Mirtazapine	Mirtazapine	51	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	12
Lovastatin	Lovastatin	47	12
Esomeprazole Magnesium	Esomeprazole Magnesium	46	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Lorazepam	Lorazepam	42	11
Humalog Kwikpen U-100	Insulin Lispro	41	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	11
Promethazine Hcl	Promethazine Hcl	39	suppressed
Sucralfate	Sucralfate	39	suppressed
Memantine Hcl	Memantine Hcl	38	suppressed
Klor-Con M20	Potassium Chloride	36	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Colestipol Hcl	Colestipol Hcl	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Lansoprazole	Lansoprazole	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Glipizide	Glipizide	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	29	24
Enalapril Maleate	Enalapril Maleate	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	20
Tradjenta	Linagliptin	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	11
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Nystatin	Nystatin	22	12
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Naproxen	Naproxen	20	suppressed
Ozempic	Semaglutide	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Baclofen	Baclofen	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Amoxicillin	Amoxicillin	18	13
Estradiol	Estradiol	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Ramipril	Ramipril	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Torsemide	Torsemide	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	11
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Verapamil Er Pm	Verapamil Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Gemtesa	Vibegron	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Cephalexin	Cephalexin	12	12
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Digoxin	Digoxin	11	suppressed
Etodolac	Etodolac	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error